leishmaniasis
DESCRIPTION
TRANSCRIPT
Leishmaniasis
Fatima Al-Awadh
INTRODUCTION
Learning Objectives
1. Define and classify parasites.
2. Explain the pathogenesis of parasite.
3. Define leishmaniasis.
4. Mention the types & causes, risk factors, signs & symptoms, diagnosis, complications, treatment & prevention.
5. Explain the life cycle of Leishmania.
What is a parasite ?
• A parasite is an organism that benefits from a close prolonged relationship with its host, which is harmed.
• The parasite grows, feeds, or uses shelter of the host organism (including the host itself) contributing negatively to the relationship.
• May be ectoparasites or endoparasites which can be intra- or extra- cellular
Classification Medically Important Parasites
Metazoa• Multicellular.• Helminthes &
Arthropods.
Protozoa• Unicellular.• Fagellates,
amoebozoa, sporozoa & ciliophora
Chromista• Unicellular.• Blastocystis
hominis.
Fungi• Unicellular.• Microsporidia.
Parasitic pathogenesis
• Given the wide diversity among human parasites, the pathogenesis is highly variable.
• Although the human parasites exhibit direct pathogenic mechanisms, in most instances the organisms themselves are not highly virulent!
Parasitic pathogenesis
Exposure and Entry
Adherence and Replication
Disruption, Evasion, and Inactivation of Host Defenses
1. E
xpos
ure
and
Ent
erin
g
Ingestion.
Direct penetration
Arthropod bite
Trans-placental penetration
Organism-directed penetration
Mediated by
Physical Chemical
Mechanical or biting mouthparts. interaction between parasite surface glycoproteins (adhesins) and specific glycoprotein or glycolipid receptors.
2.a. Adherence
2.b. Replication
• Parasites replicate intracellularly or extracellularly in human
• Helminthes generally do not replicate.• Temperature is important for the ability
to infect and cause disease.
Disruption, Evasion, and Inactivation of Host Defenses
• Like other organisms, parasites elicit humoral and cell-mediated immune responses.
• parasites are particularly adept at interfering with or avoiding these defense mechanisms.Antigen
ic variatio
n, Molecul
ar mimicry
& Maskin
g
Intra-cellular location
Immuno-
suppression
What is leishmaniasis ?
• Leishmaniasis is an infectious disease • caused by parasites belonging to genus
Leishmania • generally transmitted by the bite of
infected female Phlebotomus sand fly.
Leishmaniasis types & causes
Cutaneous leishmaniasis (CL)• Caused by L. major, L. tropica
& L. mexicana.• The most common form.• Days to few weeks.• on the extremities and face.
Leishmaniasis types & causes
Mucocutaneous leishmaniasis (ML)• Caused by L. braziliensis.• Not treated cutaneous lesion
on the face spreads to the nose or mouth.
• Months to years.• Lesions can be very
disfiguring
Leishmaniasis types & causes
Visceral leishmaniasis (VL)• Caused by L. donovani, L.
infantum & L. chagasi.• Most severe form of the
disease, fatal if untreated• Visceral disease from the
Middle East is usually milder.
Leishmania forms
Promastigote formWith flagella
Amastigote formWithout flagella
Life cycle of Leishmania
Types of leishmaniasis
“They have the same life cycle, but different tropisms generating different symptoms”
Risk factors
• The major risk factor is being exposed to infected sand flies.
• Infection is more common in adventure travelers, Corps workers, soldiers.
Risk factors
SIGNS AND SYMPTOMS
Cutaneous Mucocutaneous Visceral
one lesion or multiple lesions
initially a nodule at the bite of the sand fly
Sever weight loss
large scaly,ulcerated plaques, or shallow ulcerated nodules
nodules inside the nose, perforation of the nasal septum, and enlargement of the nose or lips
Pancytopenia
expanding and ulcerating over time
Change in voice Hepatosplenomegaly
dry or weeping Intermittent fever
painful if secondarily infected
Disfiguring scarring and tissue destruction
Hypergamma-globulinemia
Swollen lymph nodes near the sores.
Dark skin
Diagnosis
• A physical exam may show an enlarged spleen, liver, and lymph nodes. The patient may have been bitten by sandflies, or was in an area known for leishmaniasis.
Differential diagnosis
• Cutaneous leishmaniasis (CL) may look like other skin diseases, especially lepromatous leprosy, sarcoidosis, and skin cancer.
• Visceral leishmaniasis (VL) may resemble malaria or haematological malignancies.
• Mucocutaneous leishmaniasis (ML) may be similar to Tertiary syphilis.
Investigations
Cutaneous
Skin biopsy
CBC
Serologic testing
Visceral
Biopsy and culture of liver, spleen, bone marrow, or lymph
nodes
Leishmania-specific PCR test
Indirect immuno-fluorescent antibody test
Direct agglutination assay
Complication
• Fatal infections - due to immune system damage
• Bleeding (hemorrhage) VL• Facial disfigurement ML• ruptured spleen VL
Treatment
• meglumine antimonate.
• sodium stibogluconate.
Antimony-containing compounds :
• Pentamidine: CL
• amphotericin
Other drugs :
• Plastic surgery (ML).
• Splenectomy in drug-resistant (VL).
Surgery
PrognosisCutaneous Mucocutaneous Visceral
Localized cutaneous leishmaniasis lesions usually heal themselves completely.
relatively resistant to treatment.
Untreated visceral leishmaniasis has a 90% death rate, but only a 10% death rate with treatment.Diffuse cutaneous
leishmaniasis may smolder on for years without treatment
Prevention
Preventing sand fly bites is the most immediate form of protection. You can prevent a bite by:
• Putting fine mesh netting around the bed• Screening windows• Wearing insect repellent• Wearing protective clothing• Public health measures to reduce the sandfly
population and animal reservoirs. • There are no vaccines or drugs that prevent
leishmaniasis
Conclusion
References• Merck manual, Pg 1379-1381
Medical microbiology, Pg 797-801• http://www.youtube.com/watch?v=7poF
ARIxPoE• http://www.medicinenet.com/leishmania
sis/page6.htm#what_is_the_prognosis_of_leishmaniasis
• http://www.the-travel-doctor.com/leishmaniasis.htm